Covington & Burling litigators scored a major win for Eli Lilly & Co. last week when a panel of arbitrators rejected trade secret misappropriation claims by French biotech company Adocia S.A.

Adocia, which was represented by Jones Day, sought at least $1.39 billion in damages. The two companies in 2014 teamed up to develop a rapid-acting insulin.  But the collaboration didn’t last, and Adocia went on to claim Lilly misappropriated and misused its confidential information and discoveries.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]